Literature DB >> 8531102

Antinociceptive effects of cocaine/opioid combinations in rhesus monkeys.

M B Gatch1, S S Negus, E R Butelman, N K Mello.   

Abstract

This study characterized the antinociceptive effects of cocaine alone and in combination with mu, delta, and kappa opioids in rhesus monkeys. The shaved tails of four rhesus monkeys were exposed to warm water (42, 46, 50, 54, and 58 degrees C), and tail withdrawal latencies (20 sec maximum) from each temperature were determined. The temperature that produced a tail withdrawal latency of 10 sec (T10) was interpolated, and drug-induced changes in the T10 value (delta T10) were calculated. Dose-dependent increases in delta T10 were produced by cocaine (0.032-1.8 mg/kg), the high efficacy mu agonist fentanyl (0.001-0.1 mg/kg), the intermediate efficacy mu agonist morphine (0.1-18 mg/kg), the low efficacy mu agonist nalbuphine (1-32 mg/kg), and the kappa agonist U69,593 (0.0032-0.1 mg/kg). The delta agonist BW373U86 (0.56 mg/kg) produced no effect. Relative maximum effects, determined from the maximum delta T10 values produced by each drug, were fentanyl > or = (5,7,8 beta)-N-methyl-N[2-(1-pyrrolidinyl)1-oxaspiro[4,5]dec-8- yl]benzeneacetamide > morphine > nalbuphine > or = cocaine > BW373U86. When individual doses of cocaine (0.1-1.8 mg/kg) and morphine (0.32-10.0 mg/kg) were combined, cocaine produced a dose-dependent increase in the effects of each dose of morphine, and the antinociceptive effects of most cocaine/morphine combinations were significantly greater than the antinociceptive effects of either cocaine or morphine alone. Cocaine (1.8 mg/kg) was also combined with nalbuphine (1.0, 10 mg/kg), fentanyl (0.001, 0.032 mg/kg), BW373U86 (0.56 mg/kg) and U69,593 (0.0032-0.056 mg/kg). Cocaine/nalbuphine combinations produced effects markedly greater than either drug alone.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8531102

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

1.  Antinociceptive interactions between Mu-opioid receptor agonists and the serotonin uptake inhibitor clomipramine in rhesus monkeys: role of Mu agonist efficacy.

Authors:  Matthew L Banks; Kenner C Rice; S Stevens Negus
Journal:  J Pharmacol Exp Ther       Date:  2010-07-30       Impact factor: 4.030

2.  Modulation of delta opioid agonist-induced antinociception by repeated morphine pretreatment in rhesus monkeys.

Authors:  S S Negus; M L Banks; J E Folk; K C Rice
Journal:  Life Sci       Date:  2010-01-21       Impact factor: 5.037

3.  Application of Receptor Theory to the Design and Use of Fixed-Proportion Mu-Opioid Agonist and Antagonist Mixtures in Rhesus Monkeys.

Authors:  Jeremy C Cornelissen; Samuel Obeng; Kenner C Rice; Yan Zhang; S Stevens Negus; Matthew L Banks
Journal:  J Pharmacol Exp Ther       Date:  2018-01-12       Impact factor: 4.030

4.  Impact of efficacy at the μ-opioid receptor on antinociceptive effects of combinations of μ-opioid receptor agonists and cannabinoid receptor agonists.

Authors:  David R Maguire; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2014-09-05       Impact factor: 4.030

Review 5.  The search for novel analgesics: targets and mechanisms.

Authors:  Tony L Yaksh; Sarah A Woller; Roshni Ramachandran; Linda S Sorkin
Journal:  F1000Prime Rep       Date:  2015-05-26

6.  Interactions Between Opioids and Dextroamphetamine on Locomotor Activity: Influence of an Opioid's Relative Efficacy at the Mu Receptor.

Authors:  Mark A Smith; Shannon L Ballard; Clarise F Ballesteros; Samantha A Bonge; Alexander T Casimir; Lauren M Childs; Max A Feinstein; Annie K Griffith; Alexandra N Johansen; Daegeon Lee; A Caroline Mauser; Cassidy M Moses; Ian J Robertson; Javier U Robles; Justin C Strickland; Mary E Walters; Seeley J Yoo
Journal:  Front Psychiatry       Date:  2022-01-05       Impact factor: 5.435

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.